These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19023120)

  • 1. Characterization of domain-peptide interaction interface: a generic structure-based model to decipher the binding specificity of SH3 domains.
    Hou T; Xu Z; Zhang W; McLaughlin WA; Case DA; Xu Y; Wang W
    Mol Cell Proteomics; 2009 Apr; 8(4):639-49. PubMed ID: 19023120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational analysis and prediction of the binding motif and protein interacting partners of the Abl SH3 domain.
    Hou T; Chen K; McLaughlin WA; Lu B; Wang W
    PLoS Comput Biol; 2006 Jan; 2(1):e1. PubMed ID: 16446784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
    Hou T; Zhang W; Case DA; Wang W
    J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of domain-peptide interaction interface: prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based models.
    Hou T; Li N; Li Y; Wang W
    J Proteome Res; 2012 May; 11(5):2982-95. PubMed ID: 22468754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
    Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disrupting the intramolecular interaction between proto-oncogene c-Src SH3 domain and its self-binding peptide PPII with rationally designed peptide ligands.
    Zhou P; Hou S; Bai Z; Li Z; Wang H; Chen Z; Meng Y
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1122-1131. PubMed ID: 28754059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT; Serrano L; Wilmanns M
    J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why ligand cross-reactivity is high within peptide recognition domain families? A case study on human c-Src SH3 domain.
    He P; Wu W; Wang HD; Liao KL; Zhang W; Lv FL; Yang K
    J Theor Biol; 2014 Jan; 340():30-7. PubMed ID: 24021866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The high-resolution NMR structure of the R21A Spc-SH3:P41 complex: understanding the determinants of binding affinity by comparison with Abl-SH3.
    Casares S; Ab E; Eshuis H; Lopez-Mayorga O; van Nuland NA; Conejero-Lara F
    BMC Struct Biol; 2007 Apr; 7():22. PubMed ID: 17407569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neural strategy for the inference of SH3 domain-peptide interaction specificity.
    Ferraro E; Via A; Ausiello G; Helmer-Citterich M
    BMC Bioinformatics; 2005 Dec; 6 Suppl 4(Suppl 4):S13. PubMed ID: 16351739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions.
    Weng Z; Rickles RJ; Feng S; Richard S; Shaw AS; Schreiber SL; Brugge JS
    Mol Cell Biol; 1995 Oct; 15(10):5627-34. PubMed ID: 7565714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SH3 domain of nebulin binds selectively to type II peptides: theoretical prediction and experimental validation.
    Politou AS; Spadaccini R; Joseph C; Brannetti B; Guerrini R; Helmer-Citterich M; Salvadori S; Temussi PA; Pastore A
    J Mol Biol; 2002 Feb; 316(2):305-15. PubMed ID: 11851340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage display selection of ligand residues important for Src homology 3 domain binding specificity.
    Rickles RJ; Botfield MC; Zhou XM; Henry PA; Brugge JS; Zoller MJ
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10909-13. PubMed ID: 7479908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
    Han S; Liu Q; Wang F; Yuan Z
    J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reexamination of the recognition preference of the specificity pocket of the Abl SH3 domain.
    Santamaria F; Wu Z; Boulègue C; Pál G; Lu W
    J Mol Recognit; 2003; 16(3):131-8. PubMed ID: 12833568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic dissection of the binding energetics of proline-rich peptides to the Abl-SH3 domain: implications for rational ligand design.
    Palencia A; Cobos ES; Mateo PL; Martínez JC; Luque I
    J Mol Biol; 2004 Feb; 336(2):527-37. PubMed ID: 14757063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the thermodynamics of binding of an SH3 domain to proline-rich peptides using a chimeric fusion protein.
    Candel AM; van Nuland NA; Martin-Sierra FM; Martinez JC; Conejero-Lara F
    J Mol Biol; 2008 Mar; 377(1):117-35. PubMed ID: 18234212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core.
    Chen S; O'Reilly LP; Smithgall TE; Engen JR
    J Mol Biol; 2008 Nov; 383(2):414-23. PubMed ID: 18775435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn.
    Panchamoorthy G; Fukazawa T; Stolz L; Payne G; Reedquist K; Shoelson S; Songyang Z; Cantley L; Walsh C; Band H
    Mol Cell Biol; 1994 Sep; 14(9):6372-85. PubMed ID: 7520528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.